Growth-Inhibitory Effect of Hexa-N-acetyklhitohexaose and Chitohexaose against Meth-A Solid Tumor

Chemical and Pharmaceutical Bulletin

Volumn 36, Issue 2, 1988, Pages 784-790

  Tokoro, Akio ^a   Tatewaki, Nobuhiko ^a   Suzuki, Ko ^a   Mikami, Takeshi ^a   Suzuki, Shigeo ^a   Suzuki, Masuko ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

chitohexaose; growth inhibitory effect; hexa N acetylchitohexaose; interleukin 1; interleukin 2; Meth A solid tumor

Indexed keywords

HEXA N ACETYLCHITOHEXAOSE; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN METH A; CYTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; SPLEEN CELL;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL LINE; HYPERSENSITIVITY, DELAYED; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OLIGOSACCHARIDES;

EID: 0023930633     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.36.784     Document Type: Article

References (21)

1. G. Chihara, Y. Maeda, J. Hamuro, T. Sasaki and F. Fukuoka, Nature (London), 222, 687 (1969).
2. N. Komatsu, S. Okubo, S. Kikumoto, K. Kimura, G. Saito and S. Sasaki, Gann, 60, 137 (1969).
3. K. Nomoto, C. Yoshikumi and K. Matsunaga, Gann, 66, 365 (1975).
4. H. Yamagishi, N.R. Penis and B. D. Kahan, Cancer Immunol. Immunother, 9, 63 (1980).
5. S. Suzuki, M. Suzuki, H. Hatsukaiwa, H. Sunayama, T. Suzuki, M. Uchiyama, F. Fukuoka, M. Nakanishi and S. Akiya, Gann, 60, 273 (1969).
6. S. Suzuki, A. Tokoro, Y. Okawa, S. Suzuki and M. Suzuki, Chem. Pharm. Bull., 33, 886 (1985).
7. K. Suzuki, A. Tokoro, Y. Okawa, S. Suzuki and M. Suzuki, Microbiol. Immunol., 30, 777 (1986).
8. K. Suzuki, T. Mikami, Y. Okawa, A. Tokoro, S. Suzuki and M. Suzuki, Carbohydr. Res., 151, 403 (1986).
9. T. Morita, S. Tanaka, T. Nakamura and S. Iwanaga, FEBS Lett., 129, 318 (1981).
10. P. H. Lagrange, G. B. Mackaness and T. E. Mill, J. Exp. Med., 139, 528 (1974).
11. Y. Hashimoto and H. Sudo, Gann, 62, 139 (1974).
12. J. P. Fruehauf, G. D. Bonnard and R. B. Herberman, Immunopharmacology, 5, 65 (1982).
13. J. Hamuro, M. Rollinghoff and H. Wagner, Cancer Res., 38, 3080 (1978).
14. S. Gillis and S. B. Mizel, Proc. Natl. Acad. Sci. U.S.A., 78, 1133 (1981).
15. R. J. Robb, A. Munck and K. A. Smith, J. Exp. Med., 154, 1455 (1981).
16. S. Lipkowitz, W. C. Greene, A. L. Rubin, A. Novogrodsky and K. H. Stenzel, J. Immunol., 132, 31 (1984).
17. H. Wakasugi, J. Bertoglio, T. Turzu and D. Fradelizi, J. Immunol., 135, 321 (1985).
18. Z. Bar-Shavit, I. Ofec, R. Goldman, D. Mirelman and N. Sharon, Biochem. Biophys. Res. Commun., 78, 455 (1977).
19. Y. Fukazawa, K. Kagaya and H. Miura, Microbiol. Immunol., 25, 1163 (1981).
20. G. A. Warr, Biochem. Biophys. Res. Commun., 93, 737 (1980).
21. D. S. Matheson, B. J. Green and S. J. Friedman, J. Biol. Res. Mod., 3, 445 (1984).